Health
Akeso's Ivonescimab (PD-1/VEGF BsAbs) Granted Breakthrough Therapy Designation by China NMPA for the Treatment of Advanced NSCLC
HONG KONG, Oct. 20, 2022 /PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso"), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, announced that the Center for Drug Evaluation (CDE) of China Nation...
2022-10-21 09:15
1892
132nd Canton Fair Gives Full Play to the Advantages of China's Medical and Health Industry to Provide Quality Health Care Choices
GUANGZHOU, China, Oct. 20, 2022 /PRNewswire/ -- The 132nd Canton Fair, which started onOctober 15th, 2022, gathers leading companies from China's health industr -- giving full play to its industry advantages and while providing global consumers with better health care choices. Among them, Crown ...
2022-10-20 20:49
1527
Official Ground-breaking Ceremony of Wuhan Synthetic Biology Innovation Center & CABIO R&D Center Investment Project
WUHAN, China, Oct. 20, 2022 /PRNewswire/ -- On October 19th, 2022, the investment project of the CABIO R&D Center officially commenced in Wuhan Optical Valley. Upon the basis of the said investment project, the ground-breaking ceremony of the "Wuhan Synthetic Biology Innovation Center" project, ...
2022-10-20 20:30
2006
Harbour BioMed Announces Dosing of First Patient in Phase I Trial of B7H4x4-1BB Bispecific Antibody in the United States
CAMBRIDGE, Mass., ROTTERDAM and SUZHOU, China, Oct. 20, 2022 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) announced that, it has successfully completed the dosing of first patient in the global phase I trial of B7H4x4-1BB bispecific antibody HBM7008 inthe United States. This study will eva...
2022-10-20 16:20
1761
BGI Australia Receives NATA Certification for Clinical Whole Exome Sequencing
BRISBANE, Australia, Oct. 20, 2022 /PRNewswire/ -- BGI Australia's lab has achieved accreditation from the National Association of Testing Authorities (NATA) to perform clinical Whole Exome Sequencing inAustralia, paving the way for the global life sciences company to provide clinical sequencing ...
2022-10-20 15:27
1581
AASLD 2022 | Ascentage Pharma to Announce Results from First-in-Human Study of IAP Antagonist APG-1387 in an Oral Report at the AASLD Annual Meeting
SUZHOU, China and ROCKVILLE, Md., Oct. 19, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that it will release results from the Phase I fir...
2022-10-20 07:16
1448
SeekIn Presents New Data Supporting its Pan-cancer Early Detection Test at the Early Detection of Cancer Conference 2022
The large case-control study demonstrates that SeekInCare® has 68.0% sensitivity at 98.0% specificity in 27 different cancer types as a whole. In both retrospective and prospective studies, the solid performance of SeekInCare® puts it into best-in-class category of multi-cancer early detection (...
2022-10-19 20:30
1245
WeTrade Group to Increase Presence in the Health Market
BEIJING, Oct. 19, 2022 /PRNewswire/ -- WeTrade Group Inc. ("WeTrade" or the "Company") (NASDAQ: WETG), a global diversified "software as a service" ("SaaS") technology service provider which is committed to providing technical support and digital transformation tools for enterprises across differ...
2022-10-19 20:00
2395
PIVALATE ACHIEVES POSITIVE PHASE 2 DATA IN BRAIN METS TRIAL
* F-18 Pivalate PET shows high uptake regardless of origin of primary tumour * F-18 Pivalate can be used to monitor cerebral metastases * Patients without previous external beam radiation show higher tumour uptake, while those previously treated show a trend towards lower uptake MELBOURNE, A...
2022-10-19 11:12
1134
ONESOLUTION expends her IOT solution into Dental Care Market
ONESOLUTION™ and BRUSHEVA™ Engagement HONG KONG, Oct. 18, 2022 /PRNewswire/ -- ONESOLUTION INNOTECH LTD, the fully owned subsidiary of King Resources, Inc. (OTC: KRFG), the Brand and Distribution network maker of IOT products and services, today announced the extension of the product line throug...
2022-10-19 08:08
2475
STANDIGM TO ATTEND BIO-EUROPE® 2022
Standigm will present AI-driven drug discovery technology at the conference
CAMBRIDGE, England, Oct. 18, 2022 /PRNewswire/ -- Standigm
2022-10-19 01:50
1637
CARsgen Announces NDA Acceptance of BCMA CAR T Zevor-cel (CT053) by China NMPA
SHANGHAI, Oct. 18, 2022 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces thatthe National Medical Products Administration (NMPA) ofChina has a...
2022-10-18 20:50
2409
Zhiyi Biotech Received Clinical Approval from U.S. FDA for SK10 in Chemotherapy-induced Diarrhea
GUANGZHOU, China, Oct. 18, 2022 /PRNewswire/ -- Zhiyi Biotech announced that FDA has approved the Company's Investigational New Drug (IND) application to develop SK10 (InactivatedBacteroides fragilis) for the treatment of Chemotherapy-induced Diarrhea (CID) . The approval of this IND authorizes Z...
2022-10-18 20:35
1013
WeTrade Group Announces the Launch of Global Payment System WTPay and Development Plan of Health Business
BEIJING, Oct. 18, 2022 /PRNewswire/ -- WeTrade Group Inc. ("WeTrade" or the "Company") (NASDAQ: WETG), a global diversified "software as a service" ("SaaS") technology service provider which is committed to providing technical support and digital transformation tools for enterprises across differ...
2022-10-18 17:02
2995
ImmVira announced to launch the construction of Global R&D and Commercialization Base
SHENZHEN, China, Oct. 18, 2022 /PRNewswire/ -- On October 18, 2022, ImmVira launched the construction of its Global R&D and Commercialization Base in Suzhou Wuzhong Biomedical Industrial Park (Lifebay),China. The day before, ImmVira's "Shanghai Business and Clinical Center" officially opened on t...
2022-10-18 16:22
1169
EditForce Realizes RNA-editing Technology of "U-to-C"
FUKUOKA, Japan, Oct. 18, 2022 /PRNewswire/ -- EditForce, Inc. (hereinafter "EditForce"), headquartered inFukuoka, Japan, has realized the world's first RNA-editing technology that enables RNA-editing bases to be changed from "U" to "C," and demonstrated that this technology works even in human ce...
2022-10-18 14:00
1242
iNtRON developed advanced bacteriophage engineering platform technology based on modified random mutagenesis
* The transposon technology development following the customized CRISPR/Cas
system for bacteriophage
* 2nd Generation technology of Robot Bacteriophage BOSTON and SEOUL, South
Korea, Oct. 17, 2022 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON",
www.intodeworld.com
2022-10-18 11:56
1479
Axiomtek Unleashes IP69K/IP66-Rated 10.4" Stainless Steel Fanless Touch Panel Computer for Food Processing Industry - GOT810-316
TAIPEI, Oct. 17, 2022 /PRNewswire/ -- Axiomtek – a world-renowned leader relentlessly devoted in the research, development and manufacture of series of innovative and reliable industrial computer products of high efficiency – is pleased to announce theGOT810-316, a 10.4-inch stainless steel fanle...
2022-10-18 11:41
1358
InxMed Releases Data Demonstrating IN10018 Therapeutic Potential in Patients with Metastatic Melanoma at SMR 2022
NANJING, China, Oct. 17, 2022 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnology companydedicated to developing innovative therapies targeting drug resistance for hard-to-treat solid tumors, is pleased to announce that the clinical data from an open-label, phase Ib trial evaluating t...
2022-10-18 08:00
1138
Gracell Biotechnologies Doses First Patient in Phase 2 Portion of Registrational Phase 1/2 Clinical Trial Evaluating GC007g for Treatment of B-cell Acute Lymphoblastic Leukemia
Clinical trial assessing allogeneic, HLA-matched, donor-derived allogeneic CAR-T therapy SAN DIEGO, Calif., SUZHOU and SHANGHAI, China, Oct. 17, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicat...
2022-10-17 20:05
1202
Week's Top Stories
Most Reposted
Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
[Picked up by 319 media titles]
2024-11-07 09:00
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 313 media titles]
2024-11-12 09:00
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 292 media titles]
2024-11-13 09:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 291 media titles]
2024-11-12 11:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
Most Read
Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
2024-11-07 09:00
10149
XtalPi and Sinar Mas Multiartha Launch Strategic Partnership to Revolutionize AI Across Asia-Pacific
2024-11-07 11:34
7509
XTEP's First Mono Store in Malaysia Comes to Puchong
2024-11-07 10:08
6224
